AMRA inks exclusive agreement with imaging CRO in Japan

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/PhonlamaiPhoto)
(Image: Getty/PhonlamaiPhoto)

Related tags: Imaging, CRO, Japan

The digital health company AMRA has entered into an exclusive agreement with the largest imaging CRO in Japan as part of its work to provide ‘critical informatics’ to the drug development industry.

Speaking to the agreement, Rosemary Shull, senior vice president of global business development and marketing at AMRA, said Micron is a “well-established and respected company that bridges the way into Japan for AMRA.”

Micron is an imaging contract research organization (CRO) based in Japan. Headquartered in Tokyo, the company also provides imaging-related technical and clinical trial support services.

Founded in 2010 as a spin-off of Linköping University in Sweden, AMRA has developed a body composition assessment capable of producing multiple fat and muscle biomarkers, in addition to contextual disease insights, from a whole-body MRI, according to the company.

AMRA received US Food and Drug Administration (FDA) approval for the application – the AMRA Profiler – in December 2018.

“AMRA is keenly focused on providing critical informatics to the drug development and health care industries in order to better understand patients,”​ Shull said.

While AMRA is initially conducting clinical trials and academic research in Japan, Shull said the longer-term goal is “to be an integral part of what health and wellness providers offer.”

“The interest is driven by a desire for next-generation phenotyping; a far deeper look into an individual´s metabolic profile,”​ she added. “Understanding what's happening, quantitatively, reliably, and reproducibly inside your body, with a rapid MRI scan, means much more than other less robust measures of human health.”

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us

Products

View more

Webinars